The Wall Street Journal has reported that the White House is dropping its objections to the strict COVID-19 vaccine guidelines from the Food and Drug Administration.
The disagreement on those guidelines had led to worries that a vaccine would be pushed through before being proven safe.
The guidelines include a two-month safety follow-up after trials are complete, making it almost impossible for one to become available before the November election.
University of Washington President Ana Mari Cauce said, "We are calling for preserving the sanctity of the science behind their work and for the science to proceed at the speed of integrity and accuracy, not politics."
The guidelines are set to be reviewed by an advisory committee in late October.